Carrot Cells: A Pioneering Platform for Biopharmaceuticals Production

Molecular Biotechnology

Volumn 57, Issue 3, 2015, Pages 219-232

  Rosales Mendoza, Sergio ^a   Tello Olea, Marlene Anahí ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Cell suspension; Edible plant; Hairy roots; Oral vaccination; Plant based vaccine; Recombinant vaccine

Indexed keywords

CELL CULTURE; ESCHERICHIA COLI; VACCINES;

CELL SUSPENSION; EDIBLE PLANTS; HAIRY ROOTS; ORAL VACCINATIONS; RECOMBINANT VACCINES;

VIRUSES;

ALPHA GALACTOSIDASE; ALPHA2B INTERFERON; DEOXYRIBONUCLEASE I; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GLUCOSYLCERAMIDASE; HELICOBACTER PYLORI VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; VACCINE;

BORDETELLA PERTUSSIS; CALLUS (PLANT); CARROT CELL; CELL SUSPENSION; CHLAMYDIASIS; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; COTYLEDON; DIPHTHERIA; ENTEROTOXIGENIC ESCHERICHIA COLI; GAUCHER DISEASE; GENETIC ENGINEERING; GENETIC TRANSFORMATION; HELICOBACTER INFECTION; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MEASLES VIRUS; MOLECULAR FARMING; NONHUMAN; PLANT CELL; PLANT GROWTH; PROTOPLAST; REVIEW; SUBSTITUTION THERAPY; TETANUS; TISSUE CULTURE CELL; TUBERCULOSIS; VACCINATION; VACCINE PRODUCTION; VIBRIO CHOLERAE; YERSINIA PESTIS; ANIMAL; BACTERIAL INFECTIONS; CARROT; CYTOLOGY; ENZYME REPLACEMENT; GENETICS; HUMAN; METABOLISM; PHARMACEUTICS; PROCEDURES; TRANSGENIC PLANT; VIRUS DISEASES;

CHLAMYDIA TRACHOMATIS; CORYNEBACTERIUM; DAUCUS CAROTA; ESCHERICHIA COLI; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MEASLES VIRUS; MYCOBACTERIUM TUBERCULOSIS; YERSINIA PESTIS;

ANIMALS; BACTERIAL INFECTIONS; BIOPHARMACEUTICS; DAUCUS CAROTA; ENZYME REPLACEMENT THERAPY; GLUCOSYLCERAMIDASE; HUMANS; MOLECULAR FARMING; PLANTS, GENETICALLY MODIFIED; VACCINES; VIRUS DISEASES;

EID: 84923812779     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-014-9837-y     Document Type: Review

References (93)

1. Hernández, M., Rosas, G., Cervantes, J., Fragoso, G., Rosales-Mendoza, S., & Sciutto, E. (2014). Transgenic plants: A 5-year update on oral antipathogen vaccine development. Expert Review of Vaccines,27, 1–14.
2. Virdi, V., & Depicker, A. (2013). Role of plant expression systems in antibody production for passive immunization. The International Journal of Developmental Biology,57(6–8), 587–593.
3. da Cunha, N. B., Vianna, G. R., da Almeida Lima, T., & Rech, E. (2014). Molecular farming of human cytokines and blood products from plants: Challenges in biosynthesis and detection of plant-produced recombinant proteins. Biotechnology Journal,9(1), 39–50.
4. Shaaltiel, Y., Bartfeld, D., Hashmueli, S., Baum, G., Brill-Almon, E., Galili, G., et al. (2007). Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnology Journal,5(5), 579–590.
5. Protalix. Retrieved October, 2014 from http://www.protalix.com/index.asp.
6. Marquet-Blouin, E., Bouche, F. B., Steinmetz, A., & Muller, C. P. (2003). Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin. Plant Molecular Biology,51(4), 459–469.
7. Food and Agriculture Organization of the United Sations Statistics Division (FAOSTAT). Retrieved October, 2014 from http://faostat3.fao.org/faostat-gateway/go/to/home/E.
8. United States Department of Agriculture (USDA). Retrieved October, 2014 from http://nutritiondata.self.com/facts/vegetables-and-vegetable-products/2383/2.
9. Steward, F. C. (1958). Growth and development of cultured cells. III. Interpretation of the growth from free cells to carrot plant. American Journal of Botany,45, 709–713.
10. Steward, F. C., Mapes, M. O., & Smith, J. (1958). Growth and development of cultured cells. I. Growth and division of freely suspended cells. American Journal of Botany,45, 693–713.
11. Baranski, R. (2008). Genetic transformation of carrot (Daucus carota) and other Apiaceae species. Transgenic Plant Journal,2, 18–38.
12. Moscatiello, R., Baldan, B., & Navazio, L. (2013). Plant cell suspension cultures. Methods in Molecular Biology,953, 77–93.
13. Namdev, P. K., & Dunlop, E. H. (1995). Shear sensitivity of plant cells in suspensions present and future. Applied Biochemistry Biotechnology,54(1–3), 109–131.
14. Larkin, P. J., & Scowcroft, W. R. (1981). Somaclonal variation—A novel source of variability from cell cultures for plant improvement. Theoretical and Applied Genetics,60, 197–214.
15. Rosales-Mendoza, S., Soria-Guerra, R., de Jesús Olivera-Flores, M., López-Revilla, R., Argüello-Astorga, G., Jiménez-Bremont, J., et al. (2007). Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.). Plant Cell Reports,26(7), 969–976.
16. Balestrazzi, A., Carbonera, D., & Cella, R. (1991). Transformation of Daucus carota hypocotyls mediated by Agrobacterium tumefaciens. Journal of Genetics and Breeding,45, 135–140.
17. Hardegger, M., & Sturm, A. (1998). Transformation and regeneration of carrot (Daucus carota L.). Molecular Breeding,4, 119–127.
18. Pawlicki, N., Sangwan, R., & Sangwan-Norrel, B. (1992). Factors influencing the Agrobacterium tumefaciens-mediated transformation of carrot (Daucus carota L.). Plant Cell, Tissue and Organ Culture,31, 129–139.
19. Martínez-González, L., Rosales-Mendoza, S., Soria-Guerra, R. E., Moreno-Fierros, L., López-Revilla, R., Korban, S., et al. (2011). Oral immunization with a lettuce-derived Escherichia coli heat-labile toxin B subunit induces neutralizing antibodies in mice. Plant Cell, Tissue and Organ Culture,10, 441–449.
20. Luchakivskaya, Y., Kishchenko, O., Gerasymenko, I., Olevinskaya, Z., Simonenko, Y., Spivak, M., & Kuchuk, M. (2011). High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants. Plant Cell Reports,30(3), 407–415.
21. Wally, O., Jayaraj, J., & Punja, Z. K. (2008). Comparative expression of beta-glucuronidase with five different promoters in transgenic carrot (Daucus carota L.) root and leaf tissues. Plant Cell Reports,27(2), 279–287.
22. Arango, J., Salazar, B., Welsch, R., Sarmiento, F., Beyer, P., & Al-Babili, S. (2010). Putative storage root specific promoters from cassava and yam: Cloning and evaluation in transgenic carrots as a model system. Plant Cell Reports,29(6), 651–659.
23. Chilton, M. D., Tepfer, D. A., Petit, A., David, C., Casse-Delbart, F., & Tempé, J. (1982). Agrobacterium rhizogenes inserts T-DNA into the genomes of the host plant root cells. Nature,295, 432–434.
24. Skarjinskaia, M., Ruby, K., Araujo, A., Taylor, K., Gopalasamy-Raju, V., Musiychuk, K., et al. (2013). Hairy roots as a vaccine production and delivery system. Advances in Biochemical Engineering/Biotechnology,134, 115–134.
25. Kumar, S., Dhingra, A., & Daniell, H. (2004). Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance. Plant Physiology,136(1), 2843–2854.
26. Grabowski, G. A., Barton, N. W., Pastores, G., Dambrosia, J. M., Banerjee, T. K., McKee, M. A., et al. (1995). Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Annals of Internal Medicine,122, 33–39.
27. Burrow, T. A., & Grabowski, G. A. (2011). Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation (London),1, 285–293.
28. Grabowski, G. A., Golembo, M., & Shaaltiel, Y. (2014). Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology. Molecular Genetics and Metabolism,112(1), 1–8.
29. Pastores, G. M., Petakov, M., & Giraldo, P. (2014). A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of Taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Blood Cells, Molecules, & Diseases,53(4), 253–260.
30. van Dussen, L., Zimran, A., Akkerman, E. M., Aerts, J. M., Petakov, M., Elstein, D., et al. (2013). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells, Molecules, & Diseases,50, 206–211.
31. Protalix. Retrieved October, 2014 from http://www.protalix.com/development-pipeline/overview-development-pipeline.asp.
32. Protalix. Retrieved October, 2014 from http://www.protalix.com/development-pipeline/prx-112-oral-gaucher-disease.asp.
33. Armuzzi, A., Lionetti, P., Blandizzi, C., Caporali, R., Chimenti, S., Cimino, L., et al. (2014). Anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: Focus on adalimumab. International Journal of Immunopathology and Pharmacology,27(1 Suppl), 11–32.
34. Protalix. Retrieved October, 2014 from http://www.protalix.com/resources/DDW-2014-Poster-TNF.pdf.
35. Waldek, S., & Feriozzi, S. (2014). Fabry nephropathy: A review—How can we optimize the management of Fabry nephropathy? BMC Nephrology,15, 72.
36. Kizhner, T., Azulay, Y., Hainrichson, M., Tekoah, Y., Arvatz, G., Shulman, A., et al. (2014). Characterization of a chemically modified plant cell culture expressed human α-Galactosidase—A enzyme for treatment of Fabry disease. Molecular Genetics and Metabolism,. doi:10.1016/j.ymgme.2014.08.002.
37. Osman, R., Al Jamal, K. T., Kan, P. L., Awad, G., Mortada, N., El-Shamy, A. E., & Alpar, O. (2013). Inhalable DNase I microparticles engineered with biologically active excipients. Pulmonar Pharmacology Therapy,26(6), 700–709.
38. Protalix. Retrieved October, 2014 from http://www.protalix.com/development-pipeline/prx-110-dnase.asp.
39. Luchakivskaia, Iu. S., Olevinskaia, Z. M., Kishchenko, E. M., Spivak, N. Ia., & Kuchuk, N. V. (2012). Obtaining of hairy-root, callus and suspension carrot culture (Daucus carota L.) able to accumulate human interferon alpha-2b. [InlineMediaObject not available: see fulltext.] i genetika, 46(1), 18–26.
40. World Health Organization (WHO). Retrieved September, 2014 from http://www.who.int/immunization/diseases/measles/en/index.html.
41. Mossong, J., Nokes, D. J., Edmunds, W. J., Cox, M., Ratnam, S., & Muller, C. (1999). Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. American Journal of Epidemiology,150, 1238–1249.
42. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C., & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. Journal of Virology,67, 6025–6032.
43. Wild, T. F., Malvoisin, E., & Buckland, R. (1991). Measles virus: both hemagglutinin and fusion glycoproteins are required for fusion. The Journal of General Virology,72, 439–442.
44. McFarlin, D. E., Bellini, W. J., Mingioli, E. S., Behar, T. N., & Trudgett, A. (1980). Monospecific antibody to the haemagglutinin of measles virus. The Journal of General Virology,48, 425–442.
45. Giraudon, P., & Wild, F. (1985). Correlation between epitopes on hemagglutinin of measles virus and biological activities: Passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology,144, 46–58.
46. Theisen, D. M., Bouche, F. B., El Kasmi, K. C., von der Ahe, I., Ammerlaan, W., Demotz, S., & Muller, C. P. (2000). Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes. Journal of Immunological Methods,242, 145–157.
47. Theisen, D. M., Bouche, F. B., El Kasmi, K. C., von der Ahe, I., Ammerlaan, W., Demotz, S., et al. (2003). Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: A novel antigen to protect against measles. Vaccine,21(17–18), 2065–2072.
48. Bouche, F. B., Steinmetz, A., Yanagi, Y., & Muller, C. P. (2005). Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy. Vaccine,23(17–18), 2074–2077.
49. World Health Organization (WHO). Retrieved September, 2014 from http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
50. Huang, Z., Elkin, G., Maloney, B. J., Beuhner, N., Arntzen, C. J., Thanavala, Y., & Mason, H. S. (2005). Virus-like particle expression and assembly in plants: Hepatitis B and Norwalk viruses. Vaccine,23(15), 1851–1858.
51. Youm, J. W., Won, Y. S., Jeon, J. H., Ryu, C. J., Choi, Y. K., Kim, H. C., et al. (2007). Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice. Vaccine,25(3), 577–584.
52. Lou, X. M., Yao, Q. H., Zhang, Z., Peng, R. H., Xiong, A. S., & Wang, H. K. (2007). Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants. Clinical and Vaccine Immunology,14(4), 464–469.
53. Deineko, E. V., Zagorskaya, A. A., Pozdnyakov, S. G., Filipenko, E. A., Permyakova, N. V., Sidorchuk, Y. V., et al. (2009). Comparative analysis of HBV M-antigen production in leaves of individual transgenic carrot plants. Doklady Biochemistry and Biophysics,425, 76–79.
54. Mouquet, H. (2014). Antibody B cell responses in HIV-1 infection. Trends in Immunology,. doi:10.1016/j.it.2014.08.007.
55. Lindh, I., Wallin, A., Kalbina, I., Sävenstrand, H., Engström, P., Andersson, S., & Strid, A. (2009). Production of the p24 capsid protein from HIV-1 subtype C in Arabidopsis thaliana and Daucus carota using an endoplasmic reticulum-directing SEKDEL sequence in protein expression constructs. Protein Expression and Purification,66(1), 46–51.
56. Weekly Epidemiological Record (WER) (Vol. 79, pp. 301–308). Retrieved October, 2014 from http://www.who.int/wer.
57. Center for Disease Control and Prevention (CDCP). Retrieved October, 2014 from http://www.bt.cdc.gov/training/historyofbt/index.asp.
58. Henderson, D. A. (1999). The looming threat of bioterrorism. Science,283, 1279–1282.
59. Du, Y. D., Rosqvist, R., & Forsberg, A. (2002). Role of fraction 1 of Yersinia pestis in inhibition of phagocytosis. Infection and Immunity,70, 1453–1460.
60. Nakajima, R., Motin, V. L., & Brubaker, R. R. (1995). Suppression of cytokines in mice by protein A-V fusion peptide and restoration of synthesis by active immunization. Infection and Immunity,63, 3021–3029.
61. Rosales-Mendoza, S., Soria-Guerra, R. E., Moreno-Fierros, L., Han, Y., Alpuche-Solís, A. G., & Korban, S. S. (2011). Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice. Journal of Plant Physiology,168(2), 174–180.
62. Rey-Ladino, J., Ross, A. G., & Cripps, A. W. (2014). Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis. Human Vaccines & Immunotherapeutics,10(9), 2664–2673.
63. Kalbina, I., Wallin, A., Lindh, I., Engström, P., Andersson, S., & Strid, K. (2011). A novel chimeric MOMP antigen expressed in Escherichia coli, Arabidopsis thaliana, and Daucus carota as a potential Chlamydia trachomatis vaccine candidate. Protein Expression and Purification,80(2), 194–202.
64. Centers for Disease Control and Prevention (CDCP). Retrieved September, 2014 from http://www.cdc.gov/tb/topic/globaltb/default.htm.
65. World Health Organization (WHO). Retrieved September, 2014 from http://www.who.int/tb/vaccinesfaqs/en/.
66. Uvarova, E. A., Belavin, P. A., Permyakova, N. V., Zagorskaya, A. A., Nosareva, O. V., Kakimzhanova, A. A., & Deineko, E. V. (2013). Oral immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10. Biomed Research International,2013, 316304.
67. Hadfield, T., McEvoy, P., Polotsky, Y., Tzinserling, V., & Yakovlev, A. (2000). The pathology of diphtheria. Journal of Infectious Diseases,181(Suppl 1), S116–S120.
68. Guiso, N. (2009). Bordetella pertussis and pertussis vaccines. Clinical Infectious Diseases,49(10), 1565–1569.
69. Centers for Disease Control and Prevention (CDCP). Retrieved September, 2014 from http://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html.
70. Brodzik, R., Spitsin, S., Pogrebnyak, N., Tzinserling, V., & Yakovlev, A. (2009). Generation of plant-derived recombinant DTP subunit vaccine. Vaccine,27(28), 3730–3734.
71. World Health Organization (WHO). Retrieved October 2014 from http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
72. Wenneras, C., & Erling, V. (2004). Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. Journal of Health, Population, and Nutrition,22(4), 370–382.
73. Sixma, T. K., Pronk, S. E., Kalk, K. H., Wartna, E. S., van Zanten, B. A., Witholt, B., & Hol, W. G. (1991). Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature,351, 371–377.
74. Lopez, A. L., Gonzales, M. L., Aldaba, J. G., & Nair, G. B. (2014). Killed oral cholera vaccines: History, development and implementation challenges. Therapeutic Advances in Vaccines,2(5), 123–136.
75. Rosales-Mendoza, S., Soria-Guerra, R. E., López-Revilla, R., Moreno-Fierros, L., & Alpuche-Solís, A. (2008). Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Reports,27(1), 79–84.
76. Anderl, F., & Gerhard, M. (2014). Helicobacter pylori vaccination: Is there a path to protection? World Journal of Gastroenterology,20(34), 11939–11949.
77. Michetti, P., Kreiss, C., Kotloff, K. L., Porta, N., Blanco, J. L., Bachmann, D., et al. (1999). Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology,116(4), 804–812.
78. Zhang, H., Liu, M., Li, Y., He, H., Yang, G., & Zheng, C. (2010). Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori. Protein Expression and Purification,69(2), 127–131.
79. Noh, S. A., Lee, H. S., Huh, G. H., Oh, M. J., Paek, K. H., Shin, J. S., & Bae, J. M. (2012). A sweet potato SRD1 promoter confers strong root-, taproot-, and tuber-specific expression in Arabidopsis, carrot, and potato. Transgenic Research,21(2), 265–278.
80. Mihaliak, C. A., Webb, S., Miller, T., Fanton, M., Kirk, D., Cardineau G., et al. (2005). Development of plant cell produced vaccines for animal health applications. In: Proceedings of the 108th Annual Meeting of the United States Animal Health Association, Greensboro, NC (pp. 158–163).
81. Salazar-González, J. A., Bañuelos-Hernández, B., & Rosales-Mendoza, S. (2015). Current status of viral expression systems in plants and perspectives for oral vaccines development. Plant Molecular Biology. doi:10.1007/s11103-014-0279-5.
82. Yusibov, V., Streatfield, S. J., Kushnir, N., Roy, G., & Padmanaban, A. (2013). Hybrid viral vectors for vaccine and antibody production in plants. Current Pharmaceutical Design,19(31), 5574–5586.
83. Orellana-Escobedo, L., Korban, S. S., & Rosales-Mendoza, S. (2014). Seed-based expression strategies. In: S. Rosales Mendoza (Ed.), Genetically engineered plants as a source of vaccines against wide spread diseases—An integrated view. New York: Springer. ISBN 978-1-4939-0850-9.
84. Thomas, J., Guiltinan, M., Bustos, S., Thomas, T., & Nessler, C. (1989). Carrot (Daucus carota) hypocotyls transformation using Agrobacterium tumefaciens. Plant Cell Reports,8, 354–357.
85. Tokuji, Y., & Fukuda, H. (1999). A rapid method for transformation of carrot (Daucus carota L.) by using direct somatic embryogenesis. Bioscience, Biotechnology, and Biochemistry,63, 519–523.
86. Wurtele, E., & Bulka, K. (1989). A simple, efficient method for the Agrobacterium-mediated transformation of carrot callus cells. Plant Science,61, 253–262.
87. Deroles, S., Smith, M., & Lee, C. (2002). Factors affecting transformation of cell cultures from three dicotyledoneous pigment- producing species using microprojectile bombardment. Plant Cell, Tissue and Organ Culture,70, 69–76.
88. Rojas, E., Loza, E., Olivera, M., & Gomez, M. (2009). Expression of rabies virus G protein in carrots (Daucus carota). Transgenic Research,18, 911–919.
89. Annon, A., Rathore, K., & Crosby, K. (2014). Overexpression of a tobacco osmotin gene in carrot (Daucus carota L.) enhances drought tolerance. In Vitro Cellular & Developmental Biology-Plant,50, 299–306.
90. Boston, R., Becwar, M., Ryan, R., Goldsbrough, P., Larkings, B., & Hodges, (1987). Expression from heterologous promoters in electroporated carrot protoplasts. Plant Physiology,83, 742–746.
91. Dirks, R., & Sidorov, Tulmans C. (1996). A new protoplast culture system in Daucus carota L. and its application for mutant selection and transformation. Theoretical Applied Genetics,93, 809–815.
92. Scott, R., & Draper, J. (1987). Transformation of carrot tissues derived from embryogenic suspensión cells: A useful model system for gene expression studies in plants. Plant Molecular Biology,8, 265–274.
93. Gilbert, M., Zhang, Y., & Punja, Z. (1996). Introduction and expression of chitinase encoding genes in carrot following Agrobacterium-mediated transformation. In Vitro Cellular & Developmental Biology-Plant,32, 171–178.